Owen Bowden-Jones, Dima Abdulrahim

Club Drugs and Novel Psychoactive Substances

• Broschiertes Buch

Produktbeschreibung

Emerging illicit drugs pose a significant clinical challenge. This handbook offers an engaging, concise guide to managing these challenges.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: RCPsych/Cambridge University Press
• Seitenzahl: 142
• Erscheinungstermin: 8. Oktober 2020
• Englisch
• Abmessung: 190mm x 120mm x 9mm
• Gewicht: 162g
• ISBN-13: 9781911623090
• ISBN-10: 1911623095
• Artikelnr.: 59938920

Autorenporträt

Owen Bowden-Jones is Consultant in Addiction Psychiatry and Founder of the CNWL Club Drug Clinic, London, and Honorary Professor at University College London. He is Chair of the Advisory Council on the Misuse of Drugs and National Clinical Adviser to the Alcohol, Drugs and Tobacco division at Public Health England.

Inhaltsangabe

Part I: 1. Introduction 2. What are NPS and Club Drugs and why are they important
3. A brief history of NPS production and distribution
4. Drugs classification framework for Club Drugs and NPS
5. Clinical challenge of Club Drugs and NPS
Part II. Stimulant Drugs
6. Stimulant drugs: introduction
7. Stimulant drugs: cocaine
8. Stimulant drugs: amphetamine-type
9. Stimulant drugs: methamphetamine
10. Stimulant drugs: MDMA
11. Stimulant drugs: synthetic cathinones
Part III. Depressant Drugs
12. Depressant drugs: introduction
13. Depressant drugs: GHB/GBL
14. Depressant drugs: Fentanyl, Fentanyl analogues and other opioid NPS
15. Depressant drugs: Benzodiazepine NPS
16. Depressant drugs: Ketamine and its anaologues
Part IV. Synthetic Cannabinoid Receptor Agonsits
17. Synthetic cannabinoid receptor agonists (SCRAs)
Part V. Hallucinogens
18. Hallucinogens
Part VI. Concluding Remarks and References
19. Concluding Remarks
20. References.